Life Sciences - Australia
What the team is known for
King & Wood Mallesons' well-balanced practice operates in the contentious, transactional and regulatory spheres and is particularly noted for its patent litigation offering. The firm is well placed to act for new and established foreign players in the Australian life sciences market, as well as Australian companies looking to enter the Chinese and other foreign markets and innovative companies seeking to establish themselves. Similarly, its team is well equipped to provide life sciences clients with supporting expertise from all branches of a full-service firm with a particularly strong regional presence. Its notable clients include Monash University, L'Oréal and HealthyLife.
Strengths
"They are a pleasure to work with; we are always briefed by them because everything is well prepared. They have a big team and they work well together."
"The corporate governance and commercial advice is excellent."
Work highlights
King & Wood Mallesons acted for the University of Sydney on a claim by its employed researchers that it had failed to properly commercialise intellectual property that was comprised in a clinical trials database.
Notable practitioners
Matthew Swinn maintains an active IP practice in which he frequently acts for pharmaceutical and medical device companies on patent disputes.He is based in Melbourne.
Kate Hay focuses much of her practice on the representation of players in the pharmaceutical, bioscience and medical device spheres in key litigation and other IP protection mandates.
Scott Bouvier commands widespread respect for his wide-ranging commercial intellectual property practice, which covers contractual, commercialisation and contentious issues.Clients value his knowledge and experience within the life sciences, acting for pharmaceuticals and researchers. He is based in Sydney. "He is pragmatic and commercial. He engages in solutions-oriented advice."
